Short-Term Treatment with Zanamivir to Prevent Influenza: Results of a Placebo-Controlled Study
Open Access
- 1 March 2000
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 30 (3) , 587-589
- https://doi.org/10.1086/313696
Abstract
We explored the prophylactic activity of zanamivir after presumed exposure to influenza in the community. After close contacts with index cases of inKeywords
This publication has 7 references indexed in Scilit:
- Use of the Selective Oral Neuraminidase Inhibitor Oseltamivir to Prevent InfluenzaNew England Journal of Medicine, 1999
- Zanamivir in the Prevention of Influenza Among Healthy AdultsJAMA, 1999
- Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infectionsThe Lancet, 1998
- Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus InfectionsNew England Journal of Medicine, 1997
- Safety and Efficacy of the Neuraminidase Inhibitor GG167 in Experimental Human InfluenzaJAMA, 1996
- A study of intranasally administered interferon A (rIFN-α2A) for the seasonal prophylaxis of natural viral infections of the upper respiratory tract in healthy volunteersEpidemiology and Infection, 1988